Age, Biography and Wiki
Stewart Cole was born on 1955 in England, United Kingdom. Discover Stewart Cole's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 68 years old?
We recommend you to check the complete list of Famous People born on .
He is a member of famous with the age 68 years old group.
Stewart Cole Height, Weight & Measurements
At 68 years old, Stewart Cole height not available right now. We will update Stewart Cole's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Stewart Cole Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Stewart Cole worth at the age of 68 years old? Stewart Cole’s income source is mostly from being a successful . He is from United Kingdom. We have estimated
Stewart Cole's net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Stewart Cole Social Network
Timeline
Stewart Thomas Cole FRS is a British microbiologist. He is the director general of the Pasteur Institute since January 2018.
Stewart Cole was appointed as the 16th director general of the Pasteur Institute on 13 October 2017 , 130 years after its foundation, thus becoming the first non-French appointee. He took office on 2 January 2018, when he began to prepare the institute’s Strategic Plan for 2019-2023. The overarching ambition of the Strategic Plan is to give new impetus to basic research at the institute and to increase its impact on human health. Priority areas of the Strategic Plan include (re)emerging infectious diseases, antimicrobial resistance, brain connectivity and neurodegenerative diseases. From the Strategic Plan it is clear that the four missions originally defined by Louis Pasteur for his institute - research, public health, training/education and translating research into applications of value to humanity - are as relevant today as they were in 1887 when the Pasteur Institute was founded.
Stewart Cole has been active in infectious disease research and global health for many years. Between 2007 and 2017, he was a full professor and director of the Global Health Institute at the École polytechnique fédérale de Lausanne (EPFL, one of the two Swiss Federal Institutes of Technology). His laboratory at EPFL closed in December 2018. He was previously professor, senior vice president and scientific director of the Pasteur Institute in Paris (1983 – 2007), which he later rejoined as president and CEO.
Cole was scientific coordinator for the New Medicines For Tuberculosis project (NM4TB), running from 2006 to 2009 and the ensuing More Medicines For Tuberculosis project (MM4TB) running from 2011 to 2016 in the context of the FP7 European Union's Research and Innovation funding programme. This work led to the discovery of the TB drug candidate macozinone (MCZ) and the creation by EPFL of the not-for-profit spin-off iM4TB (Innovative Medicines for Tuberculosis ). MCZ is currently in phase 2 clinical trials.
Stewart Cole was born in 1955 and grew up in Wales, where he was educated at Milford Haven Grammar School and then at Ardwyn Grammar School, Aberystwyth. Following a life-threatening bout of paratyphoid he developed an interest in bacteria, viruses and infectious diseases, which led to his reading microbiology at the University of Wales, in Cardiff (now Cardiff University) followed by research for his PhD at the University of Sheffield, England. Subsequently, he was a postdoctoral fellow at the University of Umeå (Sweden) and a research assistant at the Max-Planck-Institut for Biology, Tübingen (Germany).
